Full Text

Turn on search term navigation

© 2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

The vast majority (80%) of the world’s 1.3 billion smokers live in low- and middle-income countries (LMICs), as classified by the World Bank according to gross national income.3 In line with the WHO Framework Convention on Tobacco Control (WHO FCTC), many countries have made great progress in implementing tobacco control policies, particularly LMICs in banning tobacco advertising, promotion and sponsorship (TAPS). An examination of packs from LMICs that require HWLs and tax stamps found that in four countries (Brazil, Indonesia, Thailand and Vietnam) most packs had a HWL that was obscured by the stamp.5 In Brazil and Indonesia, this practise is explicitly prohibited by law.5 The law in Vietnam does not prohibit it and the law in Thailand is ambiguous.5 There is also evidence of explicit manipulation of HWLs on smokeless tobacco packs purchased in rural India in 2017, with HWLs being blurred in parts, stretched and tinted.6 Further, HWLs on cigarette packs purchased in Pakistan, a lower middle-income country, in 2019 and 2020 were manipulated such that they were tinted, faded, blurred, the background colour was changed and the size of throat cancer included in the HWL image was reduced.7 Changes to pack structure and maximal use of surface area for advertising Larger HWLs mean less space for tobacco companies to use for marketing. Smokers and non-smokers, including adolescents, perceive flavoured products as less harmful than unflavoured ones.9 10 While some countries have banned flavour additives or characterising flavours in tobacco products,11 flavoured tobacco products remain prevalent in many other countries including in LMICs.12 Tobacco companies introduced flavour capsule cigarettes in 2007, and they have continued to gain market share worldwide.13 14 Flavour capsule cigarettes have a capsule in the filter that users can crush to release a flavour, at the time of their choosing as they smoke the cigarette. By the end of 2020, 17 countries, including 3 LMICs, had adopted plain packaging.3 Innovations in tobacco product and packaging also call for innovations in tobacco control policy—even in ‘dark’ markets with comprehensive tobacco control policies, tobacco industry marketing strategies and product offerings can fuel growth.13 25 26 An example of such tobacco control policies is a single presentation policy in Uruguay that limits tobacco companies to selling a single variant per cigarette brand which was successfully upheld against Philip Morris International’s legal threats.27 The recent regulatory challenges posed by synthetic nicotine, often not addressed by current tobacco control regulations,28 serves as a warning to anticipate other synthetic forms, such as synthetic compounds that mimic menthol’s cooling effects.29

Details

Title
Innovations that harm: tobacco product and packaging in low-income and middle-income countries
Author
Brown, Jennifer L 1   VIAFID ORCID Logo  ; Katherine Clegg Smith 2 ; Welding, Kevin 1 ; Barnoya, Joaquin 3   VIAFID ORCID Logo  ; Cohen, Joanna E 1   VIAFID ORCID Logo 

 Institute for Global Tobacco Control, Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA 
 Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA 
 Departamento de Investigacion, Unidad de Cirugia Cardiovascular, Guatemala City, Guatemala; Integra Cancer Institute, Guatemala City, Guatemala 
Pages
23-26
Section
Editorial
Publication year
2023
Publication date
Jan 2023
Publisher
BMJ Publishing Group LTD
ISSN
20558074
e-ISSN
2055642X
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2758500243
Copyright
© 2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.